US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years
- PMID: 25614141
- DOI: 10.1007/s00198-015-3026-0
US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years
Abstract
The US Preventative Services Task Force (USPSTF) recommends consideration for screening for osteoporosis in women under age 65 who have an estimated 10-year major osteoporotic fracture risk of 9.3 % or higher. We found that this threshold for osteoporosis screening in women ages 50-64 years old has a low sensitivity to detect osteoporosis.
Introduction: The US Preventative Services Task Force (USPSTF) recommends consideration of dual-energy X-ray absorptiometry (DXA) in women under ages 50-64 with a major osteoporotic fracture (MOF) risk of 9.3 % or higher, as estimated by the fracture risk assessment tool (FRAX) tool. We assessed the performance of the 9.3 % MOF risk threshold for detecting osteoporosis and evaluated whether DXA indication appeared appropriate, based on USPSTF criteria and other risk factors, at our institution.
Methods: We performed a retrospective record review of women ages 50-64.5 years old to determine clinical factors and FRAX scores of women undergoing a DXA at our institution over a 6-month period after the USPSTF recommendations were released and evaluated the sensitivity and specificity of the 9.3 % MOF threshold to detect densitometric osteoporosis. Additionally, using the USPSTF criteria and several additional risk factors, we evaluated the extent of potentially inappropriate DXA use in women ages 50 to 64 years in a large primary care practice in an academic medical center.
Results: The analysis included 465 DXA tests. The overall sensitivity and specificity of a FRAX-calculated MOF risk ≥9.3 % was 37 and 74 %, respectively, for the detection of osteoporosis. The receiver operator characteristic curve (ROC) demonstrated an area under the curve of 0.58. Lowering the FRAX risk threshold to 5.5 % would increase the sensitivity of detecting osteoporosis in our population from 37 to 80 % while reducing the specificity from 74 to 27 %. Out of 465 DXAs, 371 (79.8 %) were classified as appropriately ordered per our pre-specified criteria. Of the 120 women with osteoporosis at the hip and/or spine based on T-score values of -2.5 or less, 14 DXAs (11.7 %) were classified as potentially inappropriate based on a FRAX-predicted MOF risk less than 9.3 % and lack of additional pre-specified risk factors.
Conclusion: We found that the USPSTF-recommended MOF risk threshold of 9.3 % for osteoporosis screening in women ages 50-64 years old has a low sensitivity to detect osteoporosis.
Similar articles
-
Comparison of Clinical Risk Tools for Predicting Osteoporosis in Women Ages 50-64.J Am Board Fam Med. 2016 Mar-Apr;29(2):233-9. doi: 10.3122/jabfm.2016.02.150237. J Am Board Fam Med. 2016. PMID: 26957380
-
A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.Osteoporos Int. 2017 Nov;28(11):3107-3111. doi: 10.1007/s00198-017-4172-3. Epub 2017 Jul 30. Osteoporos Int. 2017. PMID: 28756457
-
Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.Osteoporos Int. 2018 Mar;29(3):759-767. doi: 10.1007/s00198-018-4415-y. Epub 2018 Feb 5. Osteoporos Int. 2018. PMID: 29404625
-
Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review.Curr Osteoporos Rep. 2015 Oct;13(5):287-301. doi: 10.1007/s11914-015-0282-z. Curr Osteoporos Rep. 2015. PMID: 26233285 Review.
-
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group.Osteoporos Int. 2014 May;25(5):1439-43. doi: 10.1007/s00198-014-2655-z. Epub 2014 Feb 28. Osteoporos Int. 2014. PMID: 24577348 Free PMC article.
Cited by
-
Validation of Ten Osteoporosis Screening Tools in Rural Communities of Taiwan.Calcif Tissue Int. 2024 Nov;115(5):507-515. doi: 10.1007/s00223-024-01273-6. Epub 2024 Aug 18. Calcif Tissue Int. 2024. PMID: 39155291
-
Comparison of FRAX in postmenopausal Asian women with and without type 2 diabetes mellitus: a retrospective observational study.J Int Med Res. 2020 Feb;48(2):300060519879591. doi: 10.1177/0300060519879591. Epub 2019 Oct 16. J Int Med Res. 2020. PMID: 31617425 Free PMC article.
-
Pharmacological Therapy of Osteoporosis: A Systematic Current Review of Literature.Front Pharmacol. 2017 Nov 7;8:803. doi: 10.3389/fphar.2017.00803. eCollection 2017. Front Pharmacol. 2017. PMID: 29163183 Free PMC article. Review.
-
Osteoporosis: a discussion on the past 5 years.Curr Rev Musculoskelet Med. 2017 Jun;10(2):265-274. doi: 10.1007/s12178-017-9410-y. Curr Rev Musculoskelet Med. 2017. PMID: 28389970 Free PMC article. Review.
-
Time to Clinically Relevant Fracture Risk Scores in Postmenopausal Women.Am J Med. 2017 Jul;130(7):862.e15-862.e23. doi: 10.1016/j.amjmed.2017.02.012. Epub 2017 Mar 9. Am J Med. 2017. PMID: 28285070 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
